It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

GlaxoSmithKline plc (GSK) Ordinary 25p

Sell:1,402.60p Buy:1,403.20p 0 Change: 12.20p (0.86%)
FTSE 100:0.25%
Market closed Prices as at close on 22 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 12.20p (0.86%)
Market closed Prices as at close on 22 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 12.20p (0.86%)
Market closed Prices as at close on 22 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Contact details

G S K House, 980 Great West Road
United Kingdom
+44 (020) 80475000

Important dates

Future events
Quarter 2 results 28 July 2021 28/07/21
Quarterly dividend payment date 08 July 2021 08/07/21
Past events
Quarterly ex-dividend date 20 May 2021 20/05/21
AGM 05 May 2021 05/05/21
Quarterly results 28 April 2021 28/04/21
Quarterly dividend payment date 08 April 2021 08/04/21
Annual report 09 March 2021 09/03/21
Quarterly ex-dividend date 18 February 2021 18/02/21
Final results 03 February 2021 03/02/21
Quarter 4 results 03 February 2021 03/02/21
Quarterly dividend payment date 14 January 2021 14/01/21
Quarterly ex-dividend date 12 November 2020 12/11/20
Quarter 3 results 28 October 2020 28/10/20
Quarterly dividend payment date 08 October 2020 08/10/20
Quarterly ex-dividend date 13 August 2020 13/08/20
Interim results 29 July 2020 29/07/20
Quarter 2 results 29 July 2020 29/07/20
Quarterly dividend payment date 09 July 2020 09/07/20

General stock information

Market cap:
£70.58 billion
Shares in issue:
5.03 billion
Pharmaceuticals & Biotechnology
London Stock Exchange
Sterling pence
FTSE 100,FTSE 350,FTSE All Share,FTSE techMARK All Share,FTSE 350 Higher Yield

Key personnel

  • Emma Walmsley
    Chief Executive Officer, Executive Director
  • Iain Mackay
    Chief Financial Officer, Executive Director
  • Roger Connor
    President - Global Vaccines
  • Brian McNamara
    Chief Executive Officer - GSK Consumer Healthcare
  • Luke Miels
    President - Global Pharmaceuticals
  • Regis Simard
    President - Pharmaceutical Supply Chain
  • Phil Thomson
    President - Global Affairs
  • Deborah Waterhouse
    Chief Executive Officer - ViiV Healthcare
  • James Ford
    Senior Vice President, General Counsel
  • Diana Conrad
    Senior Vice President - Human Resources

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.